about
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesMolecular profiling of endometrial malignancies.Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slugLeiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report.Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.Epidemiology and therapies for metastatic sarcomaRecent advances in understanding and managing leiomyosarcomasGenomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.Pleomorphic liposarcoma: clinical observations and molecular variables.Classification, molecular characterization, and the significance of pten alteration in leiomyosarcoma.Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma.Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.Targeted exome sequencing profiles genetic alterations in leiomyosarcoma.Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma.Bladder Leiomyosarcoma: A Rare, but Aggressive Diagnosis.The biology of uterine sarcomas: A review and update.Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experienceDual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.Retroperitoneal cavernous hemangioma resected by a pylorus preserving pancreaticoduodenectomy.Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement.Integrative genomic and transcriptomic analysis of leiomyosarcoma.Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.Prognostic significance of the alterations of the G1-S checkpoint in localized leiomyosarcoma of the peripheral soft tissue.
P2860
Q28473693-0C1DC747-1549-4214-9931-AFE05A7A4705Q33757898-98F502B2-16DE-4D7A-8C6F-9EFC9531B9ACQ34320700-5E9A1036-E66E-439A-B57C-5A06D3FA05ACQ34360332-26DAECE8-687F-408B-8EA9-48BB459B557BQ34432570-9249DFE0-EBD8-4C76-9057-2AFFAE20A925Q34607838-3C7E554B-B8A2-446C-B545-FABC7EDCF30DQ34652142-38F5C9D0-7E47-45D2-901C-4D12F5DE4E74Q34670825-A3F1AF67-C865-4C41-909B-D98356F14E6DQ34795063-02BF7AA7-99C5-4B63-B1B0-ECCD4DC1608BQ35060432-1BA3CB61-31C7-46CB-A32A-BF3A6834A1A6Q35179511-68795CD2-C9FB-44DD-A881-3A1B01AA61C6Q35788748-FC7E8888-6D33-4058-A545-03B15CCA2CE1Q35927459-FEA9F2DB-263E-47B5-B545-EF0B4F6A4312Q35948581-A90065ED-8918-4BBD-B08B-1B8C25D0EF56Q36210054-FC0DC26F-D16F-4924-98BC-ECDCF201429DQ36470353-DFCF6D13-1A45-408F-93EC-6768D4B74072Q36995072-1BAA5701-547C-4EED-8A7E-8D19FDB69BD3Q37415102-C455546D-2A1B-45DC-A391-87F5A82F905EQ37562600-0D51CAD8-FD7E-4EF9-85A2-C08BE4CFAE77Q37577932-B31EE1FC-D9F3-4360-A409-75F8E084DA51Q37702626-0926E726-951A-421B-8729-84A804DFAA51Q41660637-D7AE6E7A-8E86-4C93-A3D9-1DEB37790AB4Q43071391-D3422EBA-CAFD-4FDE-80E6-B6369E2116CBQ43274554-ED6E7442-5711-4D1C-9B0E-800F6EE3D21DQ47739736-D6824ABD-6F52-47AE-B304-B1BC1EB2E416Q48179788-29106A0A-74C3-459A-9072-788725026022Q51091546-AC4F9B66-A49C-44A3-A967-6EAFDE195341Q52320253-1BE4A74F-4B4A-4387-A6DA-FB1EE7EF0B01Q54280261-45E1D852-FDC0-4C1D-A2DF-CFDBF020A3DFQ54658620-0BCC2112-BA1B-465A-B58A-7FC7F80DBD3D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic aberrations in soft tissue leiomyosarcoma
@en
Genetic aberrations in soft tissue leiomyosarcoma.
@nl
type
label
Genetic aberrations in soft tissue leiomyosarcoma
@en
Genetic aberrations in soft tissue leiomyosarcoma.
@nl
prefLabel
Genetic aberrations in soft tissue leiomyosarcoma
@en
Genetic aberrations in soft tissue leiomyosarcoma.
@nl
P2093
P2860
P1433
P1476
Genetic aberrations in soft tissue leiomyosarcoma
@en
P2093
Alexander J F Lazar
Antti Ylipää
Jilong Yang
Jonathan Trent
Kelly Hunt
Kexin Chen
Raphael Pollock
Xiaoling Du
P2860
P356
10.1016/J.CANLET.2008.06.013
P407
P577
2008-07-22T00:00:00Z